APHIS, the Environmental Protection
Agency (EPA) and the Food and Drug Administration (FDA) have regulatory
authority over GE organisms. APHIS has the authority to regulate the
introduction of certain GE organisms and products under the Plant Protection
Act and 7 CFR § 340, but a person may petition APHIS to have a regulated
article de-regulated by showing under § 340.6 that the regulated item is
unlikely to present a greater plant pest risk than the unmodified organism. To
achieve non-regulation status, APHIS must then determine that the GE organism
is unlikely to pose a plant pest risk through thorough analysis. In addition,
the EPA has the authority to regulate pesticides under the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) 7 U.S.C. 136. Through testing, the EPA
determines if the pesticide will cause unreasonable adverse effects on humans,
the environment, and non-target species. EPA also sets tolerances for residues
of pesticides remaining on food and feed products. Lastly, the FDA regulates GE
organisms under the Federal Food Drug and Cosmetic Act (FFDCA) 21 U.S.C. 301.
FDA implements voluntary consultations to ensure that food safety issues are
resolved before commercial distribution so developers are in compliance with
Federal food safety laws prior to marketing.
Bayer petitioned APHIS that FG72
did not pose a plant pest risk in 2009. After considering several
environmental, production, socioeconomic and human and animal health issues, as
well as public comments, numerous alternatives and cumulative impacts, APHIS
granted the non-regulated status to FG72. The FDA concluded
in July of 2012 that FG72 is not materially different than comparative soybeans
now grown, marketed, and consumed in the U.S. Isoxaflutole is still under
review by the EPA, but tolerance of isoxaflutole residues has already been
established by final
rule in the Federal Register.
For more information about APHIS’s
analysis, please visit its website on
the Draft Environmental Analysis of FG72.
No comments:
Post a Comment